DAG1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C9 Genetic Test sale cost 4400 AED
POLG Gene Mitochondrial Neurogastrointestinal Encephalopathy Syndrome without Leukoencephalopathy Genetic Test sale cost 4400 AED POLG Gene Mitochondrial Neurogastrointestinal Encephalopathy Syndrome without Leukoencephalopathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DOK7 Gene Myasthenic Syndrome Congenital Type 10 Genetic Test sale cost 4400 AED DOK7 Gene Myasthenic Syndrome Congenital Type 10 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DAG1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DAG1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C9 Genetic Test” is a specialized diagnostic assessment performed to identify mutations in the DAG1 gene, which are associated with Limb-Girdle Muscular Dystrophy Type C9 (LGMD2I). This condition is part of a broader group of genetic disorders known as dystroglycanopathies, which affect the muscle’s ability to attach to the surrounding extracellular matrix, leading to progressive muscle weakness and degeneration primarily in the shoulder and hip areas.

This genetic test is crucial for confirming a clinical diagnosis, understanding the disease’s progression, and informing treatment options. It involves analyzing the patient’s DNA to look for specific mutations in the DAG1 gene that are known to cause the disorder. The test is offered at DNA Labs UAE, a reputable facility equipped with advanced genetic testing technologies to ensure accurate and reliable results.

The cost of the DAG1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C9 Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the genetic analysis, professional interpretation of the results, and a comprehensive report that can be used by healthcare providers to tailor the management and treatment plans for affected individuals. Patients considering this test are advised to consult with their healthcare providers to understand its benefits and implications fully.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DAG1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C9 Genetic Test

Test Details

DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 is a specific type of muscular dystrophy that is caused by mutations in the DAG1 gene. This gene provides instructions for making a protein called alpha-dystroglycan, which is involved in maintaining the structure and function of muscle cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9, NGS genetic testing can identify mutations or variations in the DAG1 gene that may be responsible for the condition.

This type of genetic testing can help in the diagnosis of DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 by identifying specific genetic changes that are known to be associated with the condition. It can also provide information about the inheritance pattern of the condition, which can be useful for genetic counseling and family planning.

Test Name

DAG1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C9 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for DAG1 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C9 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with DAG1 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C9

Test Process

NGS genetic testing for DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 is typically performed using a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and analyzed using sequencing technology.

Result and Treatment

The results of the test can then be used by healthcare professionals to confirm a diagnosis and provide appropriate management and treatment options for individuals with this condition.

Test Name DAG1 Gene Muscular dystrophy-dystroglycanopathy limb-girdle type C9 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DAG1 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DAG1 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C9
Test Details

DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 is a specific type of muscular dystrophy that is caused by mutations in the DAG1 gene. This gene provides instructions for making a protein called alpha-dystroglycan, which is involved in maintaining the structure and function of muscle cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9, NGS genetic testing can identify mutations or variations in the DAG1 gene that may be responsible for the condition.

This type of genetic testing can help in the diagnosis of DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 by identifying specific genetic changes that are known to be associated with the condition. It can also provide information about the inheritance pattern of the condition, which can be useful for genetic counseling and family planning.

NGS genetic testing for DAG1 gene muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 is typically performed using a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and analyzed using sequencing technology. The results of the test can then be used by healthcare professionals to confirm a diagnosis and provide appropriate management and treatment options for individuals with this condition.

SKU: TEST-1766 Category:

Related products